SuppreMol's Series D - II Round

SuppreMol raised a round of funding on May 21, 2013.

SuppreMol is a privately held biopharmaceutical company developing therapeutics for the treatment of autoimmune and allergic diseases. The company is pioneering the development of soluble Fc-gamma rec…

Articles about SuppreMol's Series D - II Round: